$BIOL BIOLASE, INC Insider Trading
Get free email notifications about insider trading in BIOLASE, INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
Overview of insider trading in BIOLASE, INC. Insider overview, share value development, latest insider transactions and email notifications about new events in BIOLASE, INC for free.
CIK Number: 0000811240
IRS Number: 870442441
Industry: DENTAL EQUIPMENT & SUPPLIES 
Trading Symbol: BIOL
Company Address: 4 CROMWELL IRVINE 92618
Phone number: 949-361-1200
Former name: LASER ENDO TECHNIC CORP, date of change: 1992-07-08
Former name: LASER MEDICAL TECHNOLOGY INC, date of change: 1994-11-17
Former name: PAMPLONA CAPITAL CORP, date of change: 1991-11-04
Former name: BIOLASE TECHNOLOGY INC, date of change: 1994-11-17
Former name: Laser Endo Technic Corporation
BIOLASE, Inc. is a medical device company, which engages in the developing, manufacturing, marketing and sale of laser systems in dentistry and medicine. It operates through the Waterlase (all-tissue) systems, and Diode (soft-tissue) systems products. The Waterlase systems use a patented combination of water and laser energy to perform procedures using drills, scalpels, and other traditional dental instruments for cutting soft and hard tissue. The Diode systems perform soft tissue, pain therapy, and cosmetic procedures, including teeth whitening. The company was founded in 1987 and is headquartered in Lake Forest, CA.
Market Capitalization: $103.37M
Prev close: $1.54
Average Daily Volume: 162,405
Days Low: $1.51
Year Low: $0.75
Year High: $1.98
BIOLASE, INC Latest Insider Transactions
|Date||Ticker||Company||Owner||Relationship||Transaction||Code||Cost ($)||Shares||Transaction Value ($)||Total Shares||% Holdings|
|Jun 14 2021||BIOL||BIOLASE, INC||BEAVER JOHN R||President & CEO||Option Exercise||A||0.00||4,144,139||0||4,144,139|
|Jun 14 2021||BIOL||BIOLASE, INC||DiTolla Michael||Director||Option Exercise||A||0.00||110,400||0||110,400|
|Jun 14 2021||BIOL||BIOLASE, INC||DiTolla Michael||Director||Option Exercise||A||0.84||104,603||87,867||104,603|
|Mar 26 2021||BIOL||BIOLASE, INC||BEAVER JOHN R||President & CEO||Option Exercise||A||0.00||100,000||0||350,692|
|Aug 10 2020||BIOL||BIOLASE, INC||BEAVER JOHN R||EVP & Chief Financi ...||Option Exercise||A||0.00||200,000||0||250,692|
|Aug 10 2020||BIOL||BIOLASE, INC||Norbe Todd||President and CEO||Option Exercise||A||0.00||200,000||0||833,333|
|Aug 10 2020||BIOL||BIOLASE, INC||LORD JONATHAN T MD||Director||Option Exercise||A||0.00||20,000||0||443,602|
|Aug 10 2020||BIOL||BIOLASE, INC||DiTolla Michael||Director||Option Exercise||A||0.00||20,000||0||273,988|
|Aug 10 2020||BIOL||BIOLASE, INC||Wagner Elaine C||Director||Option Exercise||A||0.00||20,000||0||245,856|
|Aug 10 2020||BIOL||BIOLASE, INC||Sato Garrett||Director||Option Exercise||A||0.00||20,000||0||245,856|
|Aug 10 2020||BIOL||BIOLASE, INC||ROPER JESS||Director||Option Exercise||A||0.00||20,000||0||260,397|
|Aug 10 2020||BIOL||BIOLASE, INC||Lanman Richard B.||Director||Option Exercise||A||0.00||20,000||0||245,856|
|Jul 23 2020||BIOL||BIOLASE, INC||LORD JONATHAN T MD||Director||Option Exercise||A||0.40||6||2||6|
|Jul 23 2020||BIOL||BIOLASE, INC||LORD JONATHAN T MD||Director||Option Exercise||A||0.40||15,000||6,000||15,000|
|Jul 23 2020||BIOL||BIOLASE, INC||Norbe Todd||President and CEO||Option Exercise||A||0.40||3||1||3|